ScienceDex / Researcher record
Rathmacher, John A
- Mti Biotech, Inc. (no department on record)
- Metabolic Technologies, Inc. (no department on record)
From the FY2017 NIH awards this investigator leads as contact PI. The department is the award's.
- Rising Star
NIH Funding · FY2017
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2010 | $100,000 | 1 | #40,435 |
| 2014 | $526,586 | 2 | #14,662 |
| 2016 | $1,047,478 | 2 | #6,516 |
| 2017 | $932,018 | 4 | #7,608 |
| 2021 | $656,580 | 2 | #16,236 |
| 2023 | $1,173,060 | 1 | #8,302 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20101 record
- FY20142 records
- FY20162 records
- FY2017 · selected4 records
- FY20212 records
- FY20231 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2010 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2017 award records by amount
NIH award records listing Rathmacher, John A as a PI. Multi-PI records show the full award amount for context.
- 6R44AG055184-03R44Contact PI2-Hydroxybenzylamine for the prevention of Alzheimer's disease: Initial evaluation in humans$605.2Kaward amount
- 3R44AG055184-02S1R44Contact PI2-Hydroxybenzylamine for the prevention of Alzheimer's disease: Initial evaluation in humans$150.6Kaward amount
- 3R44AG034722-03S1R44Contact PINutritional Intervention for Age-Related Muscular Function and Strength Losses$97.7Kaward amount
- 5R44AG055184-02R44Contact PI2-Hydroxybenzylamine for the prevention of Alzheimer's disease: Initial evaluation in humans$78.4Kaward amount
Award organizations
Organizations that administered FY2017 awards listing Rathmacher, John A as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2010First NIH AwardMti Biotech, Inc.
- 2014$500K Cumulative Funding
- 2014Multi-Institutional ResearchAwards at 2 institutions
- 2016$1M Cumulative Funding
- 2016Entered Top 50% NationallyRanked #6516
- 2017$2M Cumulative Funding